DR. FALK PHARMA GMBH v. GENERICO, LLC , No. 17-2312 (Fed. Cir. 2019)
Annotate this CaseThis opinion or order relates to an opinion or order originally issued on February 20, 2019.
Download PDF
NOTE: This disposition is nonprecedential. United States Court of Appeals for the Federal Circuit ______________________ July 11, 2019 ERRATUM ______________________ Appeal No. 2017-2312 DR. FALK PHARMA GMBH, Appellant v. GENERICO, LLC, FLAT LINE CAPITAL LLC, MYLAN PHARMACEUTICALS INC., Appellees -------------------------------------------------Appeal Nos. 2017-2636, 2018-1320 SALIX PHARMACEUTICALS, INC., DR. FALK PHARMA GMBH, Plaintiffs-Appellants v. MYLAN PHARMACEUTICALS INC., MYLAN INC., Defendants-Appellees Decided June 12, 2019 Nonprecedential Opinion 2 DR. FALK PHARMA GMBH v. GENERICO, LLC ______________________ The following change has been made: Page 16, line 16, “district court” has been changed to “Board.”
Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You should read the full case before relying on it for legal research purposes.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
